Harmony Biosciences Holdings Inc's Company Valuation
Currency: USD Updated: 2026-07-28
Previous score
8.09
Change
0
The current valuation score of Harmony Biosciences Holdings Inc is 8.09, ranking 100 out of 155 in the Pharmaceuticals industry. Its current P/E ratio is 14.15, which is 41.96% below the recent high of 20.09 and 46.28% above the recent low of 7.60.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.